Global Clobazam Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Clobazam Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Clobazam (marketed under the brand names Frisium, Urbanol, Onfi, and Tapclob ) is a benzodiazepine class medication that was patented in 1968 and has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984.
Clobazam report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Clobazam market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Geriatric are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Clobazam industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Clobazam key manufacturers include Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal, Merck KGaA, Breckenridge Pharmaceutical, Upsher-Smith and Hikma, etc. Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal are top 3 players and held % sales share in total in 2022.
Clobazam can be divided into 10mg/Pcs and 20mg/Pcs, etc. 10mg/Pcs is the mainstream product in the market, accounting for % sales share globally in 2022.
Clobazam is widely used in various fields, such as Adults, Geriatric and Children,, etc. Adults provides greatest supports to the Clobazam industry development. In 2022, global % sales of Clobazam went into Adults filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Clobazam market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Lupin Pharmaceuticals
ROSEMONT Pharma
Amneal
Merck KGaA
Breckenridge Pharmaceutical
Upsher-Smith
Hikma
Segment by Type
10mg/Pcs
20mg/Pcs
Adults
Geriatric
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Clobazam market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Clobazam, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Clobazam industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Clobazam in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Clobazam introduction, etc. Clobazam Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Clobazam market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Clobazam report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Clobazam market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Geriatric are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Clobazam industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Clobazam key manufacturers include Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal, Merck KGaA, Breckenridge Pharmaceutical, Upsher-Smith and Hikma, etc. Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal are top 3 players and held % sales share in total in 2022.
Clobazam can be divided into 10mg/Pcs and 20mg/Pcs, etc. 10mg/Pcs is the mainstream product in the market, accounting for % sales share globally in 2022.
Clobazam is widely used in various fields, such as Adults, Geriatric and Children,, etc. Adults provides greatest supports to the Clobazam industry development. In 2022, global % sales of Clobazam went into Adults filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Clobazam market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Lupin Pharmaceuticals
ROSEMONT Pharma
Amneal
Merck KGaA
Breckenridge Pharmaceutical
Upsher-Smith
Hikma
Segment by Type
10mg/Pcs
20mg/Pcs
Segment by Application
Adults
Geriatric
Children
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Clobazam market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Clobazam, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Clobazam industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Clobazam in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Clobazam introduction, etc. Clobazam Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Clobazam market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.